TrialScientific reports2022

Effect of linagliptin plus insulin in comparison to insulin alone on metabolic control and prognosis in hospitalized patients with SARS-CoV-2 infection.

Rodolfo Guardado-Mendoza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.